Richard S. Kollender
Director
Mr. Kollender has served as a partner at Quaker Partners, a venture capital firm with a focus on the life sciences industry, since October 2005. Mr. Kollender joined Quaker Partners as a principal in 2003. Prior to joining Quaker Partners, he served in a variety of sales, marketing and worldwide business development positions at GlaxoSmithKline, as an Investment Manager at SR One and as a Certified Public Accountant with KPMG LLP, with a significant emphasis on the healthcare and emerging businesses sectors.
Mr. Kollender holds a B.A. from Franklin and Marshall College and an M.B.A. and Health Administration & Policy degrees with Honors from the University of Chicago. He also serves on the boards of directors of Precision Therapeutics and Rapid Micro Biosystems and is an active board observer for several other Quaker Partners portfolio companies.
